Project Details


In the current proposal, explant micropropagation (in vitro tissue culture), clustered regularly interspaced short palindromic repeats (CRISPR), CRISPR/Cas9-equipped Agrobacterium-mediated Genome Editing (GE) and novel analytical and computational approaches will be tested, developed and optimized for the genetic engineering of multiple cannabis cultivars owned by the Company (Bud & Tender Ltd.).
The goal is to produce cannabinoids more cheaply, efficiently and reliably through the development of new therapeutic GE-cannabis cultivars with increased ratios of targeted therapeutically cannabinoids for medical and wellness treatments.
StatusNot started


Explore the research topics touched on by this project. These labels are generated based on the underlying awards/grants. Together they form a unique fingerprint.